Geode Capital Management, LLC Kronos Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 453,500 shares of KRON stock, worth $458,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
453,500
Previous 459,288
1.26%
Holding current value
$458,035
Previous $569,000
20.39%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KRON
# of Institutions
57Shares Held
20.5MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.79 Million3.21% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$2.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.94 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.45 Million0.1% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.32 Million0.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $57.3M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...